James Treadwell - Glioblastoma Multiforme Grade IV
To fully utilize this article, click on the blue text to link to the source being discussed..
James Treadwell was diagnosed with a Glioblastoma Multiforme Grade IV brain tumor in 2004. He has been cancer-free since 2006. An MRI performed in 2010 has confirmed that he is still cancer-free today.
#1 Diagnosis - Pathologists performed a biopsy at the Naval Medical Center in San Diego, CA establishing his diagnosis [view PDF]. A second opinion was sought at the UCLA Medical Center which also verified his diagnosis [view PDF]. Baseline MRI: 9/22/2004 [view image]
#2 Prior Treatment - Prior to Antineoplaston treatment, James Treadwell underwent two surgeries (craniotomies), a Gliadel wafer placement, six weeks of standard radiation treatment (from June 22 to August 4, 2004), three cycles of Temodar® chemotherapy (from June 23 to August 20, 2004). None of these treatments cured Mr. Treadwell of his cancer. In fact, after the second surgery no residual cancer was found, and after the course of radiation and chemotherapy his cancer had returned and doubled in size by September 14, 2004. This is defined as a recurrence.
#3 Recovery - After two surgeries, a Gliadel wafer, and 6 weeks of both chemotherapy and radiation failed to rid Mr. Treadwell of his brain cancer—on September 24, 2004 James Treadwell was admitted for administration of Antineoplaston treatment. He did not receive any other treatment other than Antineoplaston treatment after September 24, 2004. On November 30, 2006 his cancer was gone [view PDF of tumor measurements] [view PDF of his Antineoplaston treatment summary] [view a November 30, 2006 MRI image] [view a September 2008 followup MRI image].
#4 Treating Glioblastoma Multiforme Grade IV without using Antineoplastons - In 2010, some German scientists have admitted total defeat: "For patients with relapsed GBM [Glioblastoma Multiforme] there is currently no standard systemic therapy."
The New England Journal of Medicine Published a study from 2005 stated: "Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy. In this trial we compared radiotherapy alone with radiotherapy plus temozolomide [Temodar®], given concomitantly with and after radiotherapy, in terms of efficacy and safety." This is the same treatment Mr. Treadwell received prior to being treated with Antineoplastons.
#5 FDA supervised clinical trial data comparing radiation, chemotherapy, and gene-targeted therapy (other than Antineoplastons) to Antineoplaston therapy for Glioblastoma Multiforme Grade IV - Radiation & Chemotherapy in 798 patients = 0% 5-year survival; Gene-targeted drugs other than Antineoplastons in 671 patients = 0% 5-year survival; 368 patients treated with Antineoplastons = 5.25% survival. [Read the full report for yourself - PDF].
It should be noted that Senator Ted Kennedy died of Glioblastoma Grade IV brain cancer. Countless Glioblastoma survivors cured by Antineoplastons as well as many other people cured of other types of cancer due to Antineoplastons flooded Kennedy's office to share with him the existence of Antineoplastons. Mr. Kennedy's wife wrote the Burzynski's Clinic requesting all communication from Antineoplaston treated cancer survivors stop contacting his office entirely. A year later, Kennedy was dead.
Lt. Col. James Treadwell's medical records are published by written authorization by Lt. Col. James Treadwell.